CV Sciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
CV Sciences, Inc. (CVSI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 14.45 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2026-08-13
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2026-06-30 was 0.00 shares.
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2026-03-31 was 14.45M shares, a 3.34% decline year-over-year.
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-12-31 was 0.00 shares.
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-09-30 was 0.00 shares.
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2025 was 14.95M shares, a 6.03% increase from fiscal 2024.
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2024 was 14.10M shares, a 77.36% increase from fiscal 2023.
- CV Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2023 was 7.95M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 14.45M shares 10-Q · filed 2026-08-13 | 14.45M shares derived: sum of 3 quarters · filed 2026-08-13 | 14.45M shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 14.45M shares 10-Q · filed 2026-05-15 | 14.45M shares derived: sum of 2 quarters · filed 2026-05-15 | 14.45M shares derived: sum of 3 quarters · filed 2026-05-15 | 14.45M shares derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-26 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-26 | 14.95M shares 10-K · filed 2026-03-26 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-13 | 14.95M shares 10-Q · filed 2025-11-13 | 14.95M shares derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 14.95M shares 10-Q · filed 2025-08-13 | 14.95M shares derived: sum of 3 quarters · filed 2025-08-13 | 14.95M shares derived: sum of 4 quarters · filed 2025-08-13 |
| 2025-03-31 | 14.95M shares 10-Q · filed 2025-05-14 | 14.95M shares derived: sum of 2 quarters · filed 2025-05-14 | 14.95M shares derived: sum of 3 quarters · filed 2025-05-14 | 29.05M shares derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 0.00 shares derived: sum of 2 quarters · filed 2025-03-27 | 14.10M shares derived: sum of 3 quarters · filed 2025-03-27 | 14.10M shares 10-K · filed 2025-03-27 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 14.10M shares derived: sum of 2 quarters · filed 2024-11-14 | 14.10M shares 10-Q · filed 2024-11-14 | 14.35M shares derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | 14.10M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 14.10M shares 10-Q · filed 2024-08-13 | 14.35M shares derived: sum of 3 quarters · filed 2024-08-13 | 14.35M shares derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-15 | 250.00K shares derived: sum of 2 quarters · filed 2024-05-15 | 250.00K shares derived: sum of 3 quarters · filed 2024-05-15 | 500.00K shares derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-12-31 | 250.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | 250.00K shares derived: sum of 2 quarters · filed 2024-03-29 | 500.00K shares derived: sum of 3 quarters · filed 2024-03-29 | 7.95M shares 10-K · filed 2024-03-29 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 250.00K shares derived: sum of 2 quarters · filed 2023-11-14 | 7.70M shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 250.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 7.70M shares 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | 7.45M shares 10-Q · filed 2023-05-15 | |||
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 0.00 shares 10-Q · filed 2022-08-15 | ||
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-16 |